Literature DB >> 11299817

Serum ceruloplasmin in melanoma patients.

M R Ros-Bullón1, P Sánchez-Pedreño, J H Martínez-Liarte.   

Abstract

We have studied the serum ceruloplasmin levels as a possible diagnostic factor or marker for detection, diagnosis and follow-up of patients with melanoma. Ceruloplasmin concentration was determined in 64 melanoma patients (MP) and in 37 healthy persons (HP) by nephelometry. We found a mean value of 29.85 +/- 5.47 mg/dl in MP and 26.10 +/- 5.22 mg/dl in HP. A significant increase in the levels of serum ceruloplasmin was observed in MP in comparison to those in HP (P = 0.0011). In order to check whether this test could discriminate between MP and HP, a complete statistical Receiver Operating Characteristic (ROC) curve analysis was performed. The cut-off value was 25.10 mg/dl. The area under the curve was 0.689. According to these results, the test could discriminate adequately between the two groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299817

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix.

Authors:  Dae Hoon Jeong; Hyoung Kyu Kim; Abd-Ei Bary Prince; Dae Sim Lee; Young Nam Kim; Jin Han; Ki Tae Kim
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

2.  Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data.

Authors:  Lazaro Hiram Betancourt; Krzysztof Pawłowski; Jonatan Eriksson; A Marcell Szasz; Shamik Mitra; Indira Pla; Charlotte Welinder; Henrik Ekedahl; Per Broberg; Roger Appelqvist; Maria Yakovleva; Yutaka Sugihara; Kenichi Miharada; Christian Ingvar; Lotta Lundgren; Bo Baldetorp; Håkan Olsson; Melinda Rezeli; Elisabet Wieslander; Peter Horvatovich; Johan Malm; Göran Jönsson; György Marko-Varga
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

3.  Construction and Validation of a Ferroptosis-Related Prognostic Signature for Melanoma Based on Single-Cell RNA Sequencing.

Authors:  Yating Liu; Yanhong Shou; Ronghui Zhu; Zhuoqiong Qiu; Qi Zhang; Jinhua Xu
Journal:  Front Cell Dev Biol       Date:  2022-03-03

4.  Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma.

Authors:  Yeng Chen; Boon-Kiong Lim; Suat-Cheng Peh; Puteri Shafinaz Abdul-Rahman; Onn Haji Hashim
Journal:  Proteome Sci       Date:  2008-07-18       Impact factor: 2.480

Review 5.  Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis.

Authors:  Monica Neagu; Carolina Constantin; Georgiana Roxana Dumitrascu; Andreea Roxana Lupu; Constantin Caruntu; Daniel Boda; Sabina Zurac
Journal:  Discoveries (Craiova)       Date:  2015-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.